{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T20:08:59Z","timestamp":1785614939079,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014549","name":"Stanford Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA124435"],"award-info":[{"award-number":["P30CA124435"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jtocrr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTO Clinical and Research Reports"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jtocrr.2022.100323","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T12:53:02Z","timestamp":1650545582000},"page":"100323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Autoimmune Disease in Patients With Advanced Thymic Epithelial Tumors"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4307-319X","authenticated-orcid":false,"given":"Surbhi","family":"Singhal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Hellyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu M.","family":"Ouseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Wakelee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhmani K.","family":"Padda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 2","key":"10.1016\/j.jtocrr.2022.100323_bib1","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1097\/JTO.0000000000000300","article-title":"Paraneoplastic disorders in thymoma patients","volume":"9","author":"Evoli","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2022.100323_bib2","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood.V96.12.3872","article-title":"Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease","volume":"96","author":"Hoffacker","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jtocrr.2022.100323_bib3","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archinte.1974.00320200184029","article-title":"The spectrum of diseases associated with thymoma: coincidence or syndrome?","volume":"134","author":"Souadjian","year":"1974","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtocrr.2022.100323_bib4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jtocrr.2022.100323_bib5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jtho.2017.11.118","article-title":"Paraneoplastic Syndromes and thymic malignancies: an examination of the International Thymic Malignancy Interest Group Retrospective Database","volume":"13","author":"Padda","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2022.100323_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.autrev.2015.09.005","article-title":"Thymoma associated with autoimmune diseases: 85 cases and literature review","volume":"15","author":"Bernard","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jtocrr.2022.100323_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nri3667","article-title":"Positive and negative selection of the T cell repertoire: what thymocytes see (and don\u2019t see)","volume":"14","author":"Klein","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"suppl 2","key":"10.1016\/j.jtocrr.2022.100323_bib8","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1097\/JTO.0000000000000299","article-title":"Alterations of the immune system in thymic malignancies","volume":"9","author":"Weksler","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2022.100323_bib9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/path.2141","article-title":"Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1)","volume":"211","author":"Str\u00f6bel","year":"2007","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jtocrr.2022.100323_bib10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.lungcan.2015.03.007","article-title":"Does myasthenia gravis influence overall survival and cumulative incidence of recurrence in thymoma patients? A retrospective clinicopathological multicentre analysis on 797 patients","volume":"88","author":"Filosso","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2022.100323_bib12","series-title":"International Association for the Study of Lung Cancer, International Academy of Pathology. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus, and Heart","year":"2004"},{"key":"10.1016\/j.jtocrr.2022.100323_bib13","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/JTO.0000000000000654","article-title":"The 2015 World Health Organization classification of tumors of the thymus: continuity and changes","volume":"10","author":"Marx","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"issue":"suppl 3","key":"10.1016\/j.jtocrr.2022.100323_bib14","doi-asserted-by":"crossref","first-page":"S1710","DOI":"10.1097\/JTO.0b013e31821e8cff","article-title":"The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms","volume":"6","author":"Detterbeck","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2022.100323_bib15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nm.3519","article-title":"An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage","volume":"20","author":"Newman","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jtocrr.2022.100323_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jmoldx.2016.10.007","article-title":"Analytical validation of the next-generation sequencing assay for a nationwide signal-finding clinical trial: molecular analysis for therapy choice clinical trial","volume":"19","author":"Lih","year":"2017","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.jtocrr.2022.100323_bib18","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/gim.2018.3","article-title":"ClinGen\u2019s RASopathy Expert Panel consensus methods for variant interpretation","volume":"20","author":"Gelb","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.jtocrr.2022.100323_bib19","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from","volume":"76","author":"Kondo","year":"2003","journal-title":"Japan Ann Thorac Surg"},{"key":"10.1016\/j.jtocrr.2022.100323_bib20","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0003-4975(02)04083-3","article-title":"Prognostic significance of thymomas in patients with myasthenia gravis","volume":"74","author":"De Perrot","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtocrr.2022.100323_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0049-0172(98)80039-5","article-title":"Malignant thymoma associated with autoimmune diseases: a retrospective study and review of the literature","volume":"28","author":"Levy","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jtocrr.2022.100323_bib22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-4362.1992.tb02675.x","article-title":"Primary thymic carcinoma and its association with dermatomyositis and pure red cell aplasia","volume":"31","author":"Haurt","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jtocrr.2022.100323_bib23","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.38.4.580","article-title":"Myasthenia gravis and primary squamous cell carcinoma of the thymus: a case report","volume":"38","author":"DiMario","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.jtocrr.2022.100323_bib24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/021849230201000213","article-title":"Thymoma associated with pure red-cell aplasia: clinical features and prognosis","volume":"10","author":"Murakawa","year":"2002","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1016\/j.jtocrr.2022.100323_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1470-2045(18)30062-7","article-title":"Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study","volume":"19","author":"Giaccone","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtocrr.2022.100323_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s40425-019-0723-9","article-title":"Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (avelumab) treatment in advanced thymoma","volume":"7","author":"Rajan","year":"2019","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.jtocrr.2022.100323_bib27","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1200\/JCO.2017.77.3184","article-title":"Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II trial","volume":"37","author":"Cho","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2022.100323_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00095","article-title":"Sunitinib in the treatment of thymoma and associated autoimmune neutropenia","volume":"1","author":"Becker","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jtocrr.2022.100323_bib29","first-page":"169","article-title":"Effect of chemotherapy on autoimmune hepatitis in thymoma: a case report and literature review","volume":"10","author":"Mejri","year":"2013","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.jtocrr.2022.100323_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.lungcan.2020.09.006","article-title":"Everolimus in the treatment of metastatic thymic epithelial tumors","volume":"149","author":"Hellyer","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2022.100323_bib31","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/acn3.51055","article-title":"Risk of incident autoimmune diseases in patients with thymectomy","volume":"7","author":"Lin","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jtocrr.2022.100323_bib32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3346\/jkms.2004.19.1.134","article-title":"Appearance of systemic lupus erythematosus in patients with myasthenia gravis following thymectomy: two case reports","volume":"19","author":"Park","year":"2004","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.jtocrr.2022.100323_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/096120339500400108","article-title":"Appearance of systemic lupus erythematosus after thymectomy: four case reports and review of the literature","volume":"4","author":"Mevorach","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.jtocrr.2022.100323_bib34","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/rheumatology\/39.9.1044","article-title":"Thymoma-associated systematic lupus erythematosus, exacerbating after thymectomy. A case report and review of\u00a0the literature [2]","volume":"39","author":"Boonen","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtocrr.2022.100323_bib35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","article-title":"The integrated genomic landscape of thymic epithelial tumors","volume":"33","author":"Radovich","year":"2018","journal-title":"Cancer Cell"},{"issue":"suppl 2","key":"10.1016\/j.jtocrr.2022.100323_bib36","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1097\/JTO.0000000000000298","article-title":"State of the art of genetic alterations in thymic epithelial tumors","volume":"9","author":"Rajan","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2022.100323_bib37","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1200\/JCO.2011.36.0487","article-title":"Thymic malignancies: from clinical management to targeted therapies","volume":"29","author":"Kelly","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2022.100323_bib38","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.18632\/oncotarget.27978","article-title":"Genomic clustering analysis identifies molecular subtypes of thymic epithelial tumors independent of World Health Organization histologic type","volume":"12","author":"Padda","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtocrr.2022.100323_bib39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s12253-016-0144-8","article-title":"Molecular profiling of thymoma and thymic carcinoma: genetic differences and potential novel therapeutic targets","volume":"23","author":"Enkner","year":"2017","journal-title":"Pathol Oncol Res"},{"issue":"suppl 15","key":"10.1016\/j.jtocrr.2022.100323_bib40","article-title":"Clinicogenomic characterization of metastatic thymic epithelial tumors","volume":"39","author":"Ardeshir-Larijani","year":"2021","journal-title":"J\u00a0Clin Oncol"}],"container-title":["JTO Clinical and Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364322000479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364322000479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:37:20Z","timestamp":1762987040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666364322000479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2666364322000479"],"URL":"https:\/\/doi.org\/10.1016\/j.jtocrr.2022.100323","relation":{},"ISSN":["2666-3643"],"issn-type":[{"value":"2666-3643","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune Disease in Patients With Advanced Thymic Epithelial Tumors","name":"articletitle","label":"Article Title"},{"value":"JTO Clinical and Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtocrr.2022.100323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}],"article-number":"100323"}}